Clinical Trials List
2025-06-30 - 2032-05-01
Phase II
Recruiting6
-
-
Trial Applicant
Astellas Pharma Inc.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/09
Investigators and Locations
Co-Principal Investigator
- Jian-Ri Li 無
- 林雁婷 無
- Chia-Yen Lin 無
- 洪晟鈞 無
- JU-CHUAN HU 無
- 張家程 無
- 張瓈文 無
- 梅承恩 無
- Cheng-Che Chen 無
- Chuan-Shu Chen 無
- 楊哲瑞 無
- Cheng-Kuang Yang 無
- 楊涵中 無
- 裘坤元 無
- 蔡世傳 無
- 賴谷順 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hong-Cheng Gan 無
- Chun-Te Wu 無
- 沈鼎文 無
- Yung-Chang Lin 無
- PO-HUNG LIN 無
- I-hung Shao 無
- Rita cheng 無
- Jing-Ren Tseng 無
- 黃文冠 無
- Kai-Jie Yu 無
- Po-Jung Su 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wei-Ching Lin 無
- Chao-Hsiang Chang 無
- Han Chang 無
- Yi-Huei Chang 無
- Chi-Ping Huang 無
- Chi-Rei Yang 無
- 蔡禮賢 無
- Po-Fan Hsieh 無
- 謝德鈞 無
- 周楠華 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Jeng Wu 無
- 李明儒 無
- Hsiang Ying Lee 無
- Ching-Chia Li 無
- 阮雍順 無
- 張顥瀚 無
- Hsin-Chih Yeh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
19 participants
-
Global
218 participants
